Clinical research of regional arterial infusion for severe acute pancreatitis

Su-Lin LIU,Wei XIA,MENG-Yong,Rui-Xia HU,Jian-Lin FANG,Ru-Yan ZHANG,Yang LIN,Li-Xia XIAO
2014-01-01
Abstract:AIM:The purpose of the study was to research the clinical efficacy of continuous regional arterial infusion (CRAI)in treatment of severe acute pancreatitis (SAP).METHODS:Sixty cases of SAP patients were divided into two groups,CRAI group with 30 cases and conventional treating group with 30 cases.In CRAI group,Somatostatins,Danshen injections and 5-FU were pumped into the catheters in the bad flood supplying artery of pan-creas from the catheter of femoral artery by a micro pump for 24 hours,and after the symptoms and signs of SPA patients disap-peared,the catheters were moved out.In the conventional treating group,the same dose of Somatostatins,Danshen injections and 5-FU were given by intravenous infusion method. RESULTS:CRAI group as compared with conventional group showed that the clinical efficacy of CRAI group was better,shortening the time for abdominal pain (4.0 ±2.5)d vs (6.6 ±1.8)d,abdominal ten-derness (5.8 ±2.4)d vs (8.5 ±3.2)d,hemodiastase to normal (7.9 ±2.1)d vs (9.3 ±1.2)d,urine amylase to normal (10.8 ±2.1)d vs (14.5 ±2.2)d,Human Interleukin 6 (IL-6)to normal (14.3 ±2.1)d vs (24.6 ±2.2)d,Human Interleukin 8 (IL-8)to normal (16.5 ±1.7)d vs (20.4 ±2.1)d,prosta-glandin to normal (13.1 ±1.2)d vs (18.9 ±1.4)d,thrombox-ane to normal (24.6 ±1.1)d vs (32.3 ±2.8)d (P<0.05). CONCLUSION:CRAI can be used for the treatment of SAP, because of the regulation of cytokines and improving local micro-circulation,making it a better way to treat SAP.
What problem does this paper attempt to address?